3,4-Pr-PipVP
Appearance
(Redirected from 3,4-EtPV)
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
PubChem CID | |
Chemical and physical data | |
Formula | C19H27NO |
Molar mass | 285.431 g·mol−1 |
3D model (JSmol) | |
| |
|
3,4-Pr-PipVP is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug.[1]
3,4-EtPV
[edit]Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
Chemical and physical data | |
Formula | C17H23NO |
Molar mass | 257.377 g·mol−1 |
3D model (JSmol) | |
| |
|
3,4-Pr-PipVP was marketed online since 2021 as 3,4-EtPV, which is not covered by the controlled drug analogue laws in some jurisdictions such as Germany and Holland. However, while genuine 3,4-EtPV can be made and is now available from analytical suppliers as a reference standard, the benzocyclobutene ring system is relatively unstable and the synthesis is challenging, and all samples of supposed 3,4-EtPV that have been tested have proved to be 3,4-Pr-PipVP.[2]
See also
[edit]References
[edit]- ^ Pulver B, Riedel J, Westphal F, Luhn S, Schönberger T, Schäper J, Auwärter V, Luf A, Pütz M (January 2023). "A new synthetic cathinone: 3,4-EtPV or 3,4-Pr-PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances". Drug Testing and Analysis. 15 (1): 84–96. doi:10.1002/dta.3371. PMID 36136085.
- ^ Schwelm HM, Persson M, Pulver B, Huß MV, Gréen H, Auwärter V (March 2024). "Pharmacological profile, phase I metabolism, and excretion time profile of the new synthetic cathinone 3,4-Pr-PipVP". Drug Testing and Analysis. 16 (3): 277–288. doi:10.1002/dta.3538. PMID 37431186.